earnings digest health boston scientific corp boston scientific corp recorded a second quarter profit compared with a year earlier loss which reflected its guidant acquisition but implantable defibrillators and stents had a tough quarter and the natick mass medical device maker said it aims to cut expenses and staff finance chief samuel r leno said the company will discuss plans in greater detail in the fourth quarter sales of defibrillators a business the company acquired in its guidant deal were off sales of coronary stents which prop open clogged arteries down from a year ago before several medical studies raised concerns about delayed blood clots from drug coated stents 
